📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing. (2018)

First Author: Zador Z

Attributed to: Manchester Molecular Pathology Innovation Centre (MMPathIC): bridging the gap between biomarker discovery and health and wealth funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0194701

PubMed Identifier: 29558515

Publication URI: http://europepmc.org/abstract/MED/29558515

Type: Journal Article/Review

Volume: 13

Parent Publication: PloS one

Issue: 3

ISSN: 1932-6203